Javascript must be enabled to continue!
46-LB: Effect of Nonnutritive Sweetener (Sucralose) on Gut Microbiome in Asian Indian adults with Type 2 Diabetes—A Randomized Clinical Trial
View through CrossRef
Background: Non-Nutritive Sweeteners (NNS) can help reduce calorie intake when substituted for added sugar. Some studies have reported detrimental effect of NNS on gut microbiome when given at high doses in animal models. Clinical studies have been done mostly in small sample sizes. This study aims to evaluate the effect of using sucralose in coffee, tea and fruit juices on gut microbiome in Asian Indian adults with type 2 diabetes (T2D).
Method: A parallel arm, randomized trial was carried out for 12 weeks in adults with T2D aged 30-50 yrs and glycated haemoglobin between 7-11 %. Participants were randomized into Intervention group (sucralose added in beverages) and Control group (No sucralose). Both groups received standard of care for diabetes. Faecal samples were collected from participants, V3-V4 libraries were generated and sequenced using illumina Miseq NGS. Alpha and beta diversity were derived for both groups to assess within and between groups changes. Ratio of fermicutes to bacteroidetes was also computed.
Results: Interim data of 38 participants who completed the study (Control group, n=14 and Intervention group, n=24) was analysed for changes in operational taxonomical units (OTU) of gut microbiome. Major phyla detected across all samples were Fermicutes, Actinobacteria, Bacteroidetes, Proteobacteria and Verrucomicrobiota. Alpha and beta diversity analysis showed no significant changes between intervention and control groups. Fermicutes to bacteroidetes ratio did not show any significant difference between groups. At end of 12 weeks significant reduction in body weight (p<0.004) and body fat % (p<0.04) was observed in the intervention group.
Conclusion: Use of sucralose in beverages produced no significant change in gut microbiome in Asian Indian adults with T2D but helped in reduction of body weight and body fat.
Clinical trial registry: CTRI/2021/04/032686
Disclosure
V. Mohan: None. K. Abirami: None. G. Rajagopal: None. P. Soundararajan: None. R. Unnikrishnan: None. R. Anjana: None. S. Vasudevan: None. K. Kamala: None.
Funding
Zydus Wellness Products Ltd.
Title: 46-LB: Effect of Nonnutritive Sweetener (Sucralose) on Gut Microbiome in Asian Indian adults with Type 2 Diabetes—A Randomized Clinical Trial
Description:
Background: Non-Nutritive Sweeteners (NNS) can help reduce calorie intake when substituted for added sugar.
Some studies have reported detrimental effect of NNS on gut microbiome when given at high doses in animal models.
Clinical studies have been done mostly in small sample sizes.
This study aims to evaluate the effect of using sucralose in coffee, tea and fruit juices on gut microbiome in Asian Indian adults with type 2 diabetes (T2D).
Method: A parallel arm, randomized trial was carried out for 12 weeks in adults with T2D aged 30-50 yrs and glycated haemoglobin between 7-11 %.
Participants were randomized into Intervention group (sucralose added in beverages) and Control group (No sucralose).
Both groups received standard of care for diabetes.
Faecal samples were collected from participants, V3-V4 libraries were generated and sequenced using illumina Miseq NGS.
Alpha and beta diversity were derived for both groups to assess within and between groups changes.
Ratio of fermicutes to bacteroidetes was also computed.
Results: Interim data of 38 participants who completed the study (Control group, n=14 and Intervention group, n=24) was analysed for changes in operational taxonomical units (OTU) of gut microbiome.
Major phyla detected across all samples were Fermicutes, Actinobacteria, Bacteroidetes, Proteobacteria and Verrucomicrobiota.
Alpha and beta diversity analysis showed no significant changes between intervention and control groups.
Fermicutes to bacteroidetes ratio did not show any significant difference between groups.
At end of 12 weeks significant reduction in body weight (p<0.
004) and body fat % (p<0.
04) was observed in the intervention group.
Conclusion: Use of sucralose in beverages produced no significant change in gut microbiome in Asian Indian adults with T2D but helped in reduction of body weight and body fat.
Clinical trial registry: CTRI/2021/04/032686
Disclosure
V.
Mohan: None.
K.
Abirami: None.
G.
Rajagopal: None.
P.
Soundararajan: None.
R.
Unnikrishnan: None.
R.
Anjana: None.
S.
Vasudevan: None.
K.
Kamala: None.
Funding
Zydus Wellness Products Ltd.
Related Results
Separation of Sucralose in Food Samples using Amines as Background Electrolyte Supported with DFT Calculations
Separation of Sucralose in Food Samples using Amines as Background Electrolyte Supported with DFT Calculations
Background:
Sucralose is a high intensity artificial sweetener and chemically known as
1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl-4-chloro-4-deoxy-α-D-galactopyranoside. It is us...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Radiotherapy and the gut microbiome: facts and fiction
Radiotherapy and the gut microbiome: facts and fiction
AbstractAn ever-growing body of evidence has linked the gut microbiome with both the effectiveness and the toxicity of cancer therapies. Radiotherapy is an effective way to treat t...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
615-P: Effect of Nonnutritive Sweetener Sucralose on Cardiometabolic Risk Factors among Adults with Type 2 Diabetes in India—A Randomized Clinical Trial
615-P: Effect of Nonnutritive Sweetener Sucralose on Cardiometabolic Risk Factors among Adults with Type 2 Diabetes in India—A Randomized Clinical Trial
Background: Non-Nutritive sweeteners (NNS) can help in reducing calorie intake if substituted for sugar. Studies on the effect of replacing sugar with NNS in adults with type 2 dia...
Sucralose and Liver Cancer: A Molecular Insight into the Silent Risk Lurking in Everyday Sweeteners
Sucralose and Liver Cancer: A Molecular Insight into the Silent Risk Lurking in Everyday Sweeteners
Abstract
This study explores the potential link between sucralose, an artificial sweetener, and liver cancer risk. sucralose is widely used for its calorie-free sweetness, ...
Contagious Antibiotic Resistance: Plasmid Transfer Among Bacterial Residents of the Zebrafish Gut
Contagious Antibiotic Resistance: Plasmid Transfer Among Bacterial Residents of the Zebrafish Gut
Abstract
By characterizing the trajectories of antibiotic resistance gene transfer in bacterial communities such as the gut microbiome, we will b...
Gut Microbiome Alterations in COVID-19
Gut Microbiome Alterations in COVID-19
Abstract
Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, the gut microbiome in COVID-19 has garnered substantial interest, given its significan...

